Accuracy in risk understanding among BRCA1/2-mutation carriers.


Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: [Email]


BRCA1/2-mutation carriers are at high risk of developing cancer. Since they must weigh clinical recommendations and decide on risk-reducing measures, the correct understanding of their 10-year cancer risks is essential. This study focused on the accuracy of women's subjective estimates of developing breast and ovarian cancer within ten years as prerequisite to reduce unnecessary prevention.


BRCA1/2 gene mutation,Genetic counseling,Risk accuracy,Risk perception,Subjective risk estimation,

OUR Recent Articles